Bumper Offer - Urjas oil Just @ Rs. 1
Glitaris M is a prescription medicine that is available as a Tablet. Other than this, Glitaris M has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Glitaris M is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Glitaris M are Stomach Upset, Difficulty urinating, Muscle Ache. Some other side effects of Glitaris M have been listed ahead. Such side effects of Glitaris M normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Glitaris M has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Glitaris M's effects on the liver, heart and kidney, if any, have been listed below.
Glitaris M is not recommended if you suffer from certain medical conditions as it can have adverse effects. Congestive Heart Failure (CHF), Anemia, Shock are examples of such conditions. Other conditions have been mentioned below in the Glitaris M contraindications section.
Drug interactions for Glitaris M have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Glitaris M, it is important to know that it is safe while driving, and is habit-forming.
Glitaris M is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Glitaris M is used -
Severe
Moderate
Mild
Common
Is the use of Glitaris M safe for pregnant women?
Glitaris M can have harmful effects in pregnant women. If you experience any discomfort after using Glitaris M, then discontinue the use and take your doctor's advice.
Is the use of Glitaris M safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Glitaris M. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Glitaris M on the Kidneys?
Glitaris M may have mild side effects on the kidneys.
What is the effect of Glitaris M on the Liver?
Glitaris M may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glitaris M on the Heart?
You may experience side effects on your heart after taking Glitaris M. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Glitaris M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glitaris M unless your doctor advises you to do so -
Is this Glitaris M habit forming or addictive?
Forming a habit of Glitaris M has not been reported.
Interaction between Food and Glitaris M
Due to the absence of research, it is difficult to say how Glitaris M and food will interact.
Interaction between Alcohol and Glitaris M
Taking Glitaris M and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033